Table 2 Clinicopathologic features related to ANXA10 expression
ANXA10 positive N=36 | ANXA10 negative N=87 | Odds ratio | P-value | |
|---|---|---|---|---|
Location (n (%)) | 3.72 | 0.001 | ||
 Right | 25 (69%) | 33 (38%) | ||
 Left | 11 (31%) | 54 (62%) | ||
Tumor differentiation (n (%)) | — | <0.0001 | ||
 Well | 4 (11%) | 42 (48%) | ||
 Moderate | 8 (22%) | 26 (30%) | ||
 Poor | 24 (67%) | 19 (22%) | ||
Tumor histology (n (%)) | ||||
 Mucinous differentiation | 13 (36%) | 22 (25%) | 1.67 | 0.226 |
 Medullary histology | 2 (6%) | 5 (6%) | 0.97 | 0.967 |
 Signet ring histology | 5 (14%) | 0 (0%) | — | <0.0001 |
Pathologic features of invasive carcinoma (n (%)) | ||||
 Crohn’s-like reaction | 30 (83%) | 42 (48%) | 5.36 | <0.0001 |
 Tumor-infiltrating lymphocytes | 13 (36%) | 20 (23%) | 1.89 | 0.135 |
 Dirty necrosis | 10 (28%) | 60 (69%) | 0.17 | <0.0001 |
MUC5AC expression | ||||
 Positive | 33 (92%) | 34 (39%) | 17.15 | <0.0001 |
 Negative | 3 (8%) | 53 (61%) | ||
MUC6 expression | 4.69 | <0.0001 | ||
 Positive | 21 (58%) | 20 (23%) | ||
 Negative | 15 (42%) | 67 (77%) | ||
CDX2 expression | 7.54 | <0.0001 | ||
 <50% | 22 (61%) | 15 (17%) | ||
 ≧50% | 14 (39%) | 72 (83%) | ||
Molecular subgroup of carcinoma | — | <0.0001 | ||
 Group 1 (n=18) | 10 (28%) | 8 (9%) | ||
 Group 2 (n=40) | 24 (67%) | 16 (18%) | ||
 Group 3 (n=55) | 0 (0%) | 55 (63%) | ||
 Group 4 (n=10) | 2 (6%) | 8 (9%) |
